Atazanavir
Synchemia is a leading supplier in pharmaceutical Atazanavir Impurities. Atazanavir is used together with other medicines for the treatment of the infection caused by the human immunodeficiency virus (HIV). HIV is the virus that causes acquired immune deficiency syndrome (AIDS). Atazanavir will not cure or prevent HIV infection or AIDS.
Atazanavir CAS NO: 198904-31-3 chemically represented as Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate ; Dimethyl (3S,8S,9S,12S)-9-benzyl-3,12,di-tert-butyl-8-hydroxy-4,11-dioxo-6-(p-2-pyridylbenzyl)-2,5,6,10,13-pentaazatetradecanedioate, sulfate (1:1) .Synchemia is the leading supplier and exporter Atazanavir .We supply Atazanavir with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-A482 |
| CAS No | 1028634-76-5 |
| Mol.F. | C36H50N6O5 |
| Mol.Wt. | 646.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A483 |
| CAS No | NA |
| Mol.F. | C37H50N6O6 |
| Mol.Wt. | 674.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A484 |
| CAS No | 198904-34-6 |
| Mol.F. | C37H50N6O7 |
| Mol.Wt. | 690.8g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A485 |
| CAS No | NA |
| Mol.F. | C39H54N6O7 |
| Mol.Wt. | 718.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A486 |
| CAS No | NA |
| Mol.F. | C44H63N7O8 |
| Mol.Wt. | 818g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A487 |
| CAS No | 4385-62-0 |
| Mol.F. | C12H9NO2 |
| Mol.Wt. | 199.2g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A488 |
| CAS No | 127406-56-8 |
| Mol.F. | C12H9NO |
| Mol.Wt. | 183.2g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-A489 |
| CAS No | 1192224-24-0 |
| Mol.F. | C26H43N5O7 |
| Mol.Wt. | 537.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A490 |
| CAS No | NA |
| Mol.F. | C34H33N5O |
| Mol.Wt. | 527.7g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A491 |
| CAS No | 1292296-09-3 |
| Mol.F. | C38H52N6O7 |
| Mol.Wt. | 704.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A492 |
| CAS No | 1332981-14-2 |
| Mol.F. | C38H52N6O7 |
| Mol.Wt. | 704.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A493 |
| CAS No | 1332981-16-4 |
| Mol.F. | C38H52N6O7 |
| Mol.Wt. | 704.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A494 |
| CAS No | NA |
| Mol.F. | C38H52N6O7 |
| Mol.Wt. | 704.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A495 |
| CAS No | NA |
| Mol.F. | C42H46N6O4 |
| Mol.Wt. | 698.9g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-A496 |
| CAS No | 198904-85-7 |
| Mol.F. | C17H21N3O2 |
| Mol.Wt. | 299.4g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-A497 |
| CAS No | 154212-60-9 |
| Mol.F. | C8H14N2S : 2(HCl) |
| Mol.Wt. | 170.3 : 2(36.5)g/mole |
| INV STATUS | In Stock |